NewMediaWire logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

RSS Feed for NewMediaWire

Landmark Proton Therapy Data Changes the Conversation; LIXTE Biotechnology (LIXT) Saw It Coming

March 25, 2026LOS ANGELES, CA - March 25, 2026 (NEWMEDIAWIRE) - For decades, radiation oncology advanced incrementally, improving precision through software and delivery techniques while the underlying physics of photon radiation remained largely unchanged. The core limitation persisted: photon beams pass through the body, leaving an exit dose of radiation in tissue beyond the tumor.


Soligenix (SNGX) Spotlighted in Recent Zacks Research Report as Key Clinical Milestones Approach

March 25, 2026LOS ANGELES, CA - March 25, 2026 (NEWMEDIAWIRE) - Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing therapies for rare diseases and unmet medical needs, is featured in a detailed research report issued by Zacks Small-Cap Research. The March 12 report provides a comprehensive look at the company’s pipeline, financial positioning and upcoming clinical catalysts, underscoring the potential value proposition for investors as Soligenix advances multiple programs toward key inflection points.


GeoVax Provides Update on GEO-MVA Program

March 25, 2026Clinical Product Release Testing Completed in Support of Pivotal Phase 3 Trial ATLANTA, GA - March 25, 2026 (NEWMEDIAWIRE) - March 25, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies against infectious diseases and cancer, today provided a development update on its GEO-MVA vaccine program for protection against mpox and smallpox, highlighting continued progress toward initiation of its planned pivotal Phase 3 clinical study.


Critical Infrastructure Technologies and Juno Industries Execute JV Agreement to Develop and Deploy Arctic-Focused Autonomous Nexus Platform

March 25, 2026KEY HIGHLIGHTS: - Joint Venture established to develop and commercialise an Arctic-ready Nexus platform, the “Polar Nexus” - Establishment of a British Columbia facility to support Polar Nexus integration and Arctic testing - Development of the Polar Nexus platform to support Arctic communications and surveillance deployments across defence and industrial markets VANCOUVER, BC - March 25, 2026 (NEWMEDIAWIRE) - Critical Infrastructure Technologies Ltd. (CSE: CTTT) (OTC: CITLF) (FRA: X9V) (“CiTech” or the “Company”), a developer of autonomous, high-capacity mobile communications and security platforms, is pleased to announce that it has signed a Joint Venture agreement with Juno Industries (“Juno”) to co-develop and commercialise an Arctic-ready version of the Company’s Nexus platform, to be branded the “Polar Nexus.


Western Execution Readiness On Critical Minerals: Moving From Ambition To Action With "Shovel-Ready" Project

March 25, 2026By Meg Flippin, Benzinga DETROIT, MICHIGAN - March 25, 2026 (NEWMEDIAWIRE) - Canada is moving decisively from policy ambition to industrial execution as it works to secure resilient, transparent and competitive critical‑minerals supply chains for energy security and industrial sovereignty. A key part of this shift, Nouveau Monde Graphite (NYSE: NMG) has emerged as a concrete execution case, advancing a major project of national interest with committed financing, binding offtakes and construction readiness.


Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase

March 25, 2026TROY, MI - March 25, 2026 (NEWMEDIAWIRE) - Isiah Enterprises (formerly One World Products, OTCQB: OWPC) today announced the activation of its vertically integrated composite materials platform and the initiation of a strategic partner alignment phase, positioning the Company to scale across automotive, packaging, and industrial markets undergoing rapid transition toward sustainable and lightweight solutions. Isiah Enterprises has established a multi-input, multi-market platform designed to deliver engineered materials into OEM and Tier-1 supply chains.


Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase

March 25, 2026TROY, MI - March 25, 2026 (NEWMEDIAWIRE) - Isiah Enterprises (formerly One World Products, OTCQB: OWPC) today announced the activation of its vertically integrated composite materials platform and the initiation of a strategic partner alignment phase, positioning the Company to scale across automotive, packaging, and industrial markets undergoing rapid transition toward sustainable and lightweight solutions. Isiah Enterprises has established a multi-input, multi-market platform designed to deliver engineered materials into OEM and Tier-1 supply chains.


Premature Placental Separation may Increase the Child s Risk of Heart Disease by age 28

March 25, 2026Research Highlights: People born to mothers where the birth included a placental abruption (placenta separates from the uterus before delivery) may have a higher risk of developing or dying from cardiovascular disease than those whose birth did not have this complication. People born to mothers who had a placental abruption are about three times more likely to be hospitalized for cardiovascular disease by the age of 28, and about 4.


LR Health & Beauty SE Announces Successful Conclusion of the Written Procedure Initiated on 6 March 2026 Under the 2024/2028 Bonds and Issuance of Super Senior Bonds

March 24, 2026AHLEN, GERMANY - March 24, 2026 (NEWMEDIAWIRE) - On 6 March 2026, LR Health & Beauty SE (the “Company”) initiated a written procedure (the “Written Procedure”) under the terms and conditions for the Company’s 2024/2028 bonds (ISIN: NO0013149658) (the “Bonds”) to implement certain amendments to, and request certain temporary waivers under, the terms and conditions for the Bonds in order to inter alia enable the incurrence of a super senior bridge financing in the form of a new bond in the amount of EUR 10,000,000 which will rank super senior in relation to the Bonds (the “Super Senior Bond”). Deadline for voting in the Written Procedure was 15:00 hrs CET today.


ASMALLWORLD Honoured With Regional Virtuoso Award in Continental Europe for Most Engaged Member in Recognition of Their Exceptional Contribution

March 24, 2026ZURICH, SWITZERLAND - March 24, 2026 (NEWMEDIAWIRE) - Virtuoso, the leading global network specialising in luxury and experiential travel, presented its second annual regional Virtuoso Awards at its Continental Europe Forum, held 11–13 March at Tivoli Avenida Liberdade Lisbon Hotel in Lisbon, Portugal. ASMALLWORLD was among the network’s most esteemed travel agency members in Continental Europe and global preferred partners honoured with an award.


45Drives Announces Strategic Partnership With Lime Technology to Integrate Unraid OS Into Its 45HomeLab Division Platform

March 24, 2026The Integration Expands Operating System Support While Reinforcing Long-term Ownership, Flexibility, and Builder-driven Infrastructure SYDNEY, NOVA SCOTIA and SAN DIEGO, CA - March 24, 2026 (NEWMEDIAWIRE) - 45Drives, leaders in big, strong, fast open source storage solutions from homelab to enterprise, today announced a strategic partnership with Lime Technology, Inc. , the makers of Unraid OS.


Soligenix (SNGX) HyBryte Data To Be Presented At USCLC Workshop Ahead Of AAD Meeting

March 24, 2026LOS ANGELES, CA - March 24, 2026 (NEWMEDIAWIRE) - Soligenix (NASDAQ: SNGX) announced that new supportive trial data for HyBryte(TM) in the treatment of cutaneous T-cell lymphoma will be presented at the United States Cutaneous Lymphoma Consortium Workshop on March 26, 2026, ahead of the American Academy of Dermatology Annual Meeting. The presentations will highlight positive results from a long-term treatment study and a comparative analysis versus Valchlor(R), supporting HyBryte(TM) potential as a therapeutic option for CTCL.


Kairos Gold Announces Public Listing On The TSXV

March 24, 2026CALGARY, ALBERTA - March 24, 2026 (NEWMEDIAWIRE) - Kairos Gold Inc. (“Kairos” or the “Company”) is thrilled to announce that it has been approved for listing on the TSX Venture Exchange (the “TSXV”) and will commence trading under the ticker symbol “KIRO” at the opening of the market on March 26, 2026.


Beeline Holdings (BLNE) Launches Self-Service Mortgage Platform to Offer Greater Flexibility and Control to Borrowers

March 24, 2026LOS ANGELES, CA - March 24, 2026 (NEWMEDIAWIRE) - Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform redefining the path to homeownership, announced the launch of a new automated lending pathway designed to streamline the home financing process. The company recently introduced its Self-Service Mortgage Experience (“SSME”), a platform feature that allows borrowers to explore customized loan options, model mortgage scenarios and lock interest rates entirely online.


Canary Gold Corp. Reports Elevated Gold Grain Counts From Drilling Supporting Paleochannel Discovery at Madeira River Project, Brazil

March 24, 2026VANCOUVER, BRITISH COLUMBIA - March 24, 2026 (NEWMEDIAWIRE) - Canary Gold Corp. (CSE: BRAZ; OTCQB: CNYGF; Frankfurt: K5D) (“Canary Gold” or the “Company”) is pleased to report encouraging early results from its ongoing drill program at its Madeira River Project in Brazil, supporting the identification of a potentially significant paleochannel gold system.


Scientific American Highlights Scientific Discovery That Supports the Potential Use of CardioDialysis™ to Treat Neuroinflammatory Diseases

March 24, 2026SAN DIEGO, CA - March 24, 2026 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), developer of CardioDialysis(TM), a next-generation blood purification technology that enables continuous broad-spectrum clearance of inflammatory and pathogenic molecules from the bloodstream, disclosed today that researchers at Trinity College Dublin have reported the first clinical evidence of blood-brain barrier disruption and associated inflammation in living individuals suspected of having Chronic Traumatic Encephalopathy (CTE).